June 08, 2020
A Maryland federal court allowed a Canadian biotechnology company to proceed with its suit alleging that a General Dynamics subsidiary owes it nearly $13.4 million for developing a nerve agent antidote for the U.S. military, but the judge tossed three of its claims.